Healthcare stocks are lower, with the NYSE Healthcare Sector
Index down less than 0.1% but with shares of healthcare companies
in the S&P 500 falling nearly 0.9% as a group.
In company news, Oramed Pharmaceuticals Inc. (
) is down 1.7% at $6.35 a share after the maker of oral
drug-delivery systems says it has received additional patents in
Japan and Canada for its Protein Oral Delivery platform.
The company's POD technology is designed to boost protein
delivery and absorption through the digestive system and into the
ORMP shares reversed early declines and briefly touched a
session high of $6.50 each - up four cents - shortly after
reporting receipt of the new patents before retreating to negative
In other sector news,
(+) OMER, (+15.3%) Identifies six new lass A orphan G
protein-coupled receptors linked to neurologic disorders,
cardiovascular disease and cancer, paving the way for developing
drugs that target those receptors.
(-) ZLCS, (-10.4%) Completes 1-for-6 reverse stock split at
12:01 a.m. this morning as part of efforts to lift share price well
above $1 minimum needed for continued Nasdaq listing.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.